Ensuring ethical and flexible consent in cancer genomic research and clinical practice

The goal of this new project is improving informed consent around genomic testing in cancer by developing and piloting an innovative intervention for COnsent in GENomic Testing (CoGenT).

Led by: Dr Jolyn Hersch

Related publications

Previous
Previous

Diabetes smartphone apps in Western Sydney

Next
Next

Evaluating the health literacy demands of COVID-19 information